Skip to content
Head to head

ConMed vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: CNMD · ABT

Updated moments ago

1-year performance, rebased to 100

CNMD +11.8%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
CNMDABT
Snapshot
SectorMedical DevicesMedical Devices
Last price46.56103.00
Change today+0.39%-0.84%
1-year return+14.6%-15.4%
Market cap$1.39B$178.39B
52-week range31.44 – 54.8080.89 – 126.70
Valuation
P/E (TTM)19.3238.29
P/E percentile, own 5-yr range49th99th
P/B1.313.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)1.513.72
Net profit (TTM)$45.00M$6.44B
Revenue (TTM)$1.37B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)-0.7%+14.5%
Gross margin57.6%56.9%
Operating margin9.9%13.8%
Net margin5.4%9.7%
Free cash flow (TTM)$132.69M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership112.0%81.2%
Insider activity (12mo)38 buy / 6 sell36 buy / 12 sell
Short interest (% of float)6.2%1.1%
Analyst consensus100% hold (3)93% buy / 7% hold (15)
Analyst price target$50 (+6%)$122 (+18%)
StockVane view
StockVane Quant RatingC (59)D (22)
Company
Employees3,900115,000
Founded19701900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.